{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:08:56Z","timestamp":1788293336797,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"NIAID DMID","doi-asserted-by":"publisher","award":["AI140257"],"award-info":[{"award-number":["AI140257"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["NS065926"],"award-info":[{"award-number":["NS065926"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["NS098826"],"award-info":[{"award-number":["NS098826"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jpain.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:59:20Z","timestamp":1686571160000},"page":"1980-1993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-9306","authenticated-orcid":false,"given":"Moeno","family":"Kume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"DeFea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1193-9238","authenticated-orcid":false,"given":"Gregory","family":"Dussor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Boitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2023.06.006_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jpain.2023.06.006_bib2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jpain.2023.06.006_bib3","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpain.2023.06.006_bib4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1200\/JCO.2013.52.4629","article-title":"Pain in cancer survivors","volume":"32","author":"Glare","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2023.06.006_bib5","doi-asserted-by":"crossref","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","article-title":"Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention","volume":"14","author":"Grisold","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpain.2023.06.006_bib6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","article-title":"Chemotherapy-induced neuropathy: A comprehensive survey","volume":"40","author":"Miltenburg","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jpain.2023.06.006_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s43440-020-00109-y","article-title":"Chemotherapy-induced peripheral neuropathy: Part 1-current state of knowledge and perspectives for pharmacotherapy","volume":"72","author":"Salat","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jpain.2023.06.006_bib8","first-page":"e12443","article-title":"The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: A qualitative thematic synthesis","volume":"26","author":"Tanay","year":"2017","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jpain.2023.06.006_bib9","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpain.2023.06.006_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.39.3.368","article-title":"Taxol produces a predominantly sensory neuropathy","volume":"39","author":"Lipton","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2023.06.006_bib12","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: A critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpain.2023.06.006_bib13","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","article-title":"Patient perceptions associated with chemotherapy-induced peripheral neuropathy","volume":"14","author":"Tofthagen","year":"2010","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jpain.2023.06.006_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/2193-1801-3-366","article-title":"Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience","volume":"3","author":"Bhatnagar","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.jpain.2023.06.006_bib15","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","article-title":"Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer","volume":"9","author":"Speck","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jpain.2023.06.006_bib16","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.2174\/0929867326666190107163756","article-title":"Management of peripheral neuropathy induced by chemotherapy","volume":"26","author":"Fradkin","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jpain.2023.06.006_bib17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2023.06.006_bib18","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2023.06.006_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.558","article-title":"Chemotherapy-induced neuropathies-a growing problem for patients and health care providers","volume":"7","author":"Banach","year":"2017","journal-title":"Brain Behav"},{"key":"10.1016\/j.jpain.2023.06.006_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jpain.2023.06.006_bib21","unstructured":"World Health Organization. The selection\u00a0and use of essential medicines. World\u00a0Health Organization\u00a0Technical Report Series;\u00a02014:i-xiv, 1-219."},{"key":"10.1016\/j.jpain.2023.06.006_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: Microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jpain.2023.06.006_bib23","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1016\/S1074-5521(99)89002-4","article-title":"How Taxol stabilises microtubule structure","volume":"6","author":"Amos","year":"1999","journal-title":"Chem Biol"},{"key":"10.1016\/j.jpain.2023.06.006_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/cm.20283","article-title":"Live-cell analysis of mitotic spindle formation in taxol-treated cells","volume":"65","author":"Hornick","year":"2008","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.jpain.2023.06.006_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zajaczkowska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpain.2023.06.006_bib26","first-page":"389","article-title":"Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration","volume":"21","author":"Cavaletti","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jpain.2023.06.006_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpain.2023.06.006_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2011.05.004","article-title":"Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats","volume":"188","author":"Okubo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2023.06.006_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuroscience.2011.06.085","article-title":"Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain","volume":"193","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2023.06.006_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2016.01.008","article-title":"Involvement of mast cells and proteinase-activated receptor 2 in oxaliplatin-induced mechanical allodynia in mice","volume":"105","author":"Sakamoto","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/tnsci-2015-0010","article-title":"Role of PAR2 in regulating oxaliplatin-induced neuropathic pain via TRPA1","volume":"6","author":"Tian","year":"2015","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.jpain.2023.06.006_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0333102418779548","article-title":"Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice","volume":"39","author":"Hassler","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2023.06.006_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/0333102420966581","article-title":"Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine","volume":"40","author":"Kopruszinski","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2023.06.006_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/j.pain.0000000000000130","article-title":"TMPRSS2, a novel membrane-anchored mediator in cancer pain","volume":"156","author":"Lam","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib35","doi-asserted-by":"crossref","first-page":"14178","DOI":"10.1523\/JNEUROSCI.2399-12.2012","article-title":"Novel animal models of acute and chronic cancer pain: a pivotal role for PAR2","volume":"32","author":"Lam","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2023.06.006_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fendo.2018.00257","article-title":"Rheumatic disease: Protease-activated receptor-2 in synovial joint pathobiology","volume":"9","author":"McCulloch","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jpain.2023.06.006_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrd3615","article-title":"Targeting proteinase-activated receptors: therapeutic potential and challenges","volume":"11","author":"Ramachandran","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jpain.2023.06.006_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","article-title":"Legumain induces oral cancer pain by biased agonism of Protease-activated receptor-2","volume":"41","author":"Tu","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2023.06.006_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1468-2982.2007.01523.x","article-title":"Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells","volume":"28","author":"Zhang","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2023.06.006_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pharmthera.2011.01.003","article-title":"Structure, function and pathophysiology of protease activated receptors","volume":"130","author":"Adams","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2023.06.006_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease-activated receptors (PARs): Mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.jpain.2023.06.006_bib42","doi-asserted-by":"crossref","first-page":"E7438","DOI":"10.1073\/pnas.1721891115","article-title":"Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome","volume":"115","author":"Jimenez-Vargas","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpain.2023.06.006_bib43","doi-asserted-by":"crossref","first-page":"C346","DOI":"10.1152\/ajpcell.00010.2007","article-title":"Differential effects of beta-arrestins on the internalization, desensitization and ERK1\/2 activation downstream of protease activated receptor-2","volume":"293","author":"Kumar","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jpain.2023.06.006_bib44","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1038\/sj.bjp.0707507","article-title":"Proteinases and signalling: Pathophysiological and therapeutic implications via PARs and more","volume":"153","author":"Ramachandran","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2023.06.006_bib45","article-title":"The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain","volume":"5","author":"Hassler","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpain.2023.06.006_bib46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/j.pain.0000000000000125","article-title":"Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state","volume":"156","author":"Tillu","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s10194-023-01574-5","article-title":"PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model","volume":"24","author":"Mason","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bph.15903","article-title":"Beta-arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation","volume":"180","author":"Schiff","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2023.06.006_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2019.100037","article-title":"Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice","volume":"6","author":"Inyang","year":"2019","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1523\/JNEUROSCI.2661-18.2018","article-title":"Nociceptor translational profiling reveals the Ragulator-Rag GTPase complex as a critical generator of neuropathic pain","volume":"39","author":"Megat","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2023.06.006_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuropharm.2017.02.020","article-title":"Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse","volume":"117","author":"Toma","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2023.06.006_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221787","article-title":"A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN)","volume":"14","author":"Gadgil","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2023.06.006_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SPC.0000000000000204","article-title":"Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics","volume":"10","author":"Hopkins","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2023.06.006_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jpain.2023.06.006_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642420","article-title":"Neuroimmune consequences of eIF4E phosphorylation on chemotherapy-induced peripheral neuropathy","volume":"12","author":"Agalave","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpain.2023.06.006_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ynpai.2017.10.001","article-title":"The grimace scale reliably assesses chronic pain in a rodent model of trigeminal neuropathic pain","volume":"2","author":"Akintola","year":"2017","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035656","article-title":"The assessment of post-vasectomy pain in mice using behaviour and the Mouse Grimace Scale","volume":"7","author":"Leach","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2023.06.006_bib58","first-page":"42","article-title":"Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice","volume":"51","author":"Matsumiya","year":"2012","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.jpain.2023.06.006_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918763658","article-title":"A deep neural network to assess spontaneous pain from mouse facial expressions","volume":"14","author":"Tuttle","year":"2018","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jpain.2023.06.006_bib61","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","article-title":"EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy","volume":"12","author":"Lauria","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpain.2023.06.006_bib62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cell.2008.02.053","article-title":"Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1","volume":"133","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2023.06.006_bib63","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.neuron.2016.07.044","article-title":"Coupled activation of primary sensory neurons contributes to chronic pain","volume":"91","author":"Kim","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2023.06.006_bib64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pain.2010.10.030","article-title":"Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline","volume":"152","author":"Boyette-Davis","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib65","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1007\/s12035-018-1301-8","article-title":"Targeting axon integrity to prevent chemotherapy-induced peripheral neuropathy","volume":"56","author":"Chine","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jpain.2023.06.006_bib66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.npep.2014.02.001","article-title":"Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"48","author":"Ko","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jpain.2023.06.006_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1744-8069-6-76","article-title":"Prevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats","volume":"6","author":"Liu","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2023.06.006_bib69","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/0008-5472.CAN-17-1467","article-title":"Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery","volume":"78","author":"Wozniak","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrn3641","article-title":"Sensory neurons and circuits mediating itch","volume":"15","author":"LaMotte","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpain.2023.06.006_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/cr.2015.149","article-title":"Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity","volume":"26","author":"Li","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-genet-120116-024723","article-title":"Protein-coupled receptors and the biology of itch sensation","volume":"51","author":"Meixiong","year":"2017","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jpain.2023.06.006_bib73","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1233765","article-title":"The cells and circuitry for itch responses in mice","volume":"340","author":"Mishra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jpain.2023.06.006_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/j.1532-2149.2012.00219.x","article-title":"The contribution of satellite glial cells to chemotherapy-induced neuropathic pain","volume":"17","author":"Warwick","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2012.03.070","article-title":"Intercellular communication in sensory ganglia by purinergic receptors and gap junctions: Implications for chronic pain","volume":"1487","author":"Hanani","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108152","article-title":"Satellite glial cells surrounding primary afferent neurons are activated and proliferate during monoarthritis in rats: Is there a role for ATF3?","volume":"9","author":"Nascimento","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2023.06.006_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pain.2006.10.007","article-title":"Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation","volume":"129","author":"Takeda","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0304-3940(89)90364-9","article-title":"Satellite cells surrounding axotomised rat dorsal root ganglion cells increase expression of a GFAP-like protein","volume":"98","author":"Woodham","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2023.06.006_bib79","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpain.2022.11.006","article-title":"C781, a beta-arrestin biased antagonist at protease-activated receptor-2 (PAR2), displays in vivo efficacy against protease-induced pain in mice","volume":"24","author":"Kume","year":"2022","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib80","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1111\/bph.12750","article-title":"The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo","volume":"171","author":"Grace","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2023.06.006_bib81","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1113\/jphysiol.2006.121111","article-title":"Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice","volume":"578","author":"Grant","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.jpain.2023.06.006_bib82","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00424-011-1071-x","article-title":"TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism","volume":"463","author":"Materazzi","year":"2012","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jpain.2023.06.006_bib83","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1074\/jbc.M112.438184","article-title":"Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling","volume":"288","author":"Poole","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2023.06.006_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","article-title":"Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy","volume":"19","author":"Molassiotis","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpain.2023.06.006_bib85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-018-3664-y","article-title":"Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy","volume":"82","author":"Farshchian","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpain.2023.06.006_bib86","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10147-015-0810-y","article-title":"Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: A pilot randomized trial","volume":"20","author":"Hirayama","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jpain.2023.06.006_bib87","first-page":"1491","article-title":"Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study","volume":"20","author":"Yang","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2023.06.006_bib88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2023.06.006_bib89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2023.06.006_bib90","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1158\/1078-0432.CCR-18-2152","article-title":"Recent developments of novel pharmacologic therapeutics for prevention of chemotherapy-induced peripheral neuropathy","volume":"25","author":"Hu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib91","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3748\/wjg.v24.i10.1120","article-title":"Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma","volume":"24","author":"Sun","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jpain.2023.06.006_bib92","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.3390\/ijms18112494","article-title":"Proteinase-activated receptor 2 may drive cancer progression by facilitating TGF-beta signaling","volume":"18","author":"Ungefroren","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpain.2023.06.006_bib93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.117.245027","article-title":"A potent antagonist of protease-activated receptor 2 that inhibits multiple signaling functions in human cancer cells","volume":"364","author":"Jiang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2023.06.006_bib94","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/aps.2016.58","article-title":"Quercetin ameliorates paclitaxel-induced neuropathic pain by stabilizing mast cells, and subsequently blocking PKCepsilon-dependent activation of TRPV1","volume":"37","author":"Gao","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jpain.2023.06.006_bib95","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/cr.2014.106","article-title":"Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter","volume":"24","author":"Liu","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"Peters","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2023.06.006_bib97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2007.06.066","article-title":"An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat","volume":"1168","author":"Peters","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib98","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2014.844792","article-title":"Protease-activated receptor 2 signalling pathways: A role in pain processing","volume":"18","author":"Bao","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jpain.2023.06.006_bib100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.33549\/physiolres.933269","article-title":"The role of protease-activated receptor type 2 in nociceptive signaling and pain","volume":"65","author":"Mrozkova","year":"2016","journal-title":"Physiol Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2008.07.001","article-title":"The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats","volume":"1229","author":"Cata","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2023.06.006_bib102","doi-asserted-by":"crossref","first-page":"e1861","DOI":"10.1053\/j.gastro.2011.07.035","article-title":"Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice","volume":"141","author":"Cattaruzza","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpain.2023.06.006_bib103","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.0000072792.65250.4A","article-title":"Neutrophil elastase in human atherosclerotic plaques: production by macrophages","volume":"107","author":"Dollery","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpain.2023.06.006_bib104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/j.pain.0000000000002033","article-title":"Sex-dependent role of microglia in disulfide high mobility group box 1 protein-mediated mechanical hypersensitivity","volume":"162","author":"Agalave","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jphs.2021.11.003","article-title":"Role of neuron-derived ATP in paclitaxel-induced HMGB1 release from macrophages and peripheral neuropathy","volume":"148","author":"Domoto","year":"2022","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jpain.2023.06.006_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/j.pain.0000000000002034","article-title":"Sex- and cell-dependent contribution of peripheral high mobility group box 1 and TLR4 in arthritis-induced pain","volume":"162","author":"Rudjito","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2023.06.006_bib108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/ijms22010367","article-title":"Role of HMGB1 in chemotherapy-induced peripheral neuropathy","volume":"22","author":"Sekiguchi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpain.2023.06.006_bib109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2016.06.050","article-title":"Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy","volume":"333","author":"Duggett","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2023.06.006_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2006.01.037","article-title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","volume":"122","author":"Flatters","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib111","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpain.2022.10.015","article-title":"Meteorin alleviates paclitaxel-induced peripheral neuropathic pain in mice","volume":"24","author":"Sankaranarayanan","year":"2023","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.06.006_bib112","article-title":"Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fumagalli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpain.2023.06.006_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113695","article-title":"Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitability","volume":"341","author":"Leo","year":"2021","journal-title":"Exp Neurol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023004418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023004418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:12:35Z","timestamp":1761509555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590023004418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":113,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1526590023004418"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2023.06.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.12.528175","asserted-by":"object"}]},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}]}}